ASTROTECH Corp
Close on Oct 19, 2026
- Market cap
- $8.41M
- P/E (TTM)
- –
- Dividend yield
- –
About Astrotech
Laboratory Analytical Instruments, SIC 3826
Astrotech Corporation commercializes analytical instruments centered on mass spectrometry and gas chromatography platforms through several dedicated operating subsidiaries. Its product lineup includes trace detection systems for explosives and narcotics, agricultural mass spectrometers for cannabis and hemp oil distillation, breath analysis screening tools for disease detection, and rugged portable gas chromatographs for environmental soil, water, and air monitoring. The company also pursues industrial process control solutions to improve manufacturing yields. Astrotech serves customers across cargo and passenger aviation, border security, military, agriculture, environmental consulting, and chemical processing sectors.
The enterprise conducts business internationally, with field deployments of its security trace detection units spanning approximately 37 locations across 16 countries in the United States, Europe, and Asia. Operations and customer trial engagements are supported from the company's headquarters located in Austin, Texas. Astrotech was organized in 1984 as a Delaware corporation.
Summary of the business section of Astrotech's latest annual report, written by StockData.
Company profile
Company
- Legal name
- ASTROTECH Corp
- Founded
- 1984
- Headquarters
- Austin, TX
- Address
- 2105 Donley Dr. Suite 100 78758
- Phone
- (512) 485-9530
- Website
- www.astrotechcorp.com
- Employees
- 28, Jun 30, 2026
- Industry
- Laboratory Analytical Instruments
- Incorporated in
- Delaware
- Fiscal year ends
- June 30
- Auditor
- RBSM LLP, Houston, Texas
Stock & identifiers
- Ticker
- ASTC
- Exchange
- Nasdaq
- Shares outstanding
- 2M, Sep 23, 2026
- Public float
- $5.26M, Dec 31, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-30 reverse, Feb 13, 2023; 1-for-30 reverse, Dec 5, 2022; 1-for-5 reverse, Oct 16, 2017; 1-for-5 reverse, Oct 16, 2017; 1-for-10 reverse, Nov 29, 2007
- SEC CIK
- 1001907
- CUSIP
- 046484309
- ISIN
- US0464843095
- LEI
- 984500DA81B780C7D558
- EIN
- 91-1273737
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Thomas Boone Pickens III | CEO, Director | 181,385 |
| Nihanth Badugu | Chief Operating Officer | 5,000 |
| Scott Bartley | Interim CFO, Treasurer and Sec | 0 |
| Jennifer Canas | Chief Financial Officer | 5,250 |
| Ryan Polk | Chief Financial Officer | 0 |
| Robert N. McFarland | Director | 10,900 |
| Eric Stober | Director | 19,654 |
| Charles Arch Winn | Director | 24,814 |
| John William Halinski | Director | 12,211 |
| Tom Wilkinson | Director | 30,923 |
| Matthew Kreps | Director | 2,150 |
| Thomas Wiley Wilkinson | Director | 23,862 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $954.85K | $696.28K | $225.89K | $15 | – |
| FY2024 | $1.33M | $969.73K | $640.00K | $22 | – |
| FY2023 | $482.96K | $517.76K | $328.35K | $35 | – |
| FY2022 | $1.96M | $492.08K | $337.91K | $32 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Employees
Headcount reported in annual reports
“As of June 30, 2026, we employed 28 employees, none of which were covered by any collective bargaining agreements.”
Corporate history
Events identified from SEC filings